
Idiopathic thrombocytopenic purpura program in Pharmaceutical Benefits Scheme (PBS) 012-18051121

-   Background
-   Process
-   Resources

[Expand/Collapse all sections]Expand all

This document outlines PBS subsidised eltrombopag and romiplostim for
patients with severe chronic immune idiopathic thrombocytopenic purpura
(ITP).

ITP and listing dates

Idiopathic thrombocytopenic purpura (ITP) is a condition with isolated
low platelet counts and an increased tendency for patients to bleed.

Listing dates:

-   romiplostim - 1 April 2011
-   eltrombopag - 1 November 2011

See Written Authority Required Drugs for more information.

Enquiries

Transfer enquiries about prescription arrangements to the PBS Complex
Drugs Programs team and choose the option relevant to the condition
treated.

The Resources page contains links to restriction and item codes, contact
details, application forms, and the PBS and Services Australia websites.

Related links

Written Authority Required Drugs

Process telephone authority approval application

Processing Written Authority Required Listings

Processing and National Demand Allocation (PaNDA)

Online Pharmaceutical Benefits Scheme (PBS) Authorities System (OPA)

                                   

-   Services Australia ABN 90 794 605 008 
